BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6648771)

  • 1. The selective use of modified human umbilical vein as an arterial substitute in the lower extremity.
    Buth J; Cohen RF; Adhin SK
    Surg Gynecol Obstet; 1983 Dec; 157(6):523-9. PubMed ID: 6648771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biogenic grafts in arterial surgery--long-term results (I. The homologous vein--II. The modified heterologous bovine carotid artery--III. The human umbilical vein).
    Sciacca V; Walter G; Becker HM
    Thorac Cardiovasc Surg; 1984 Jun; 32(3):157-64. PubMed ID: 6206595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors determining late patency of aortobifemoral bypass graft].
    Davidović LB; Lotina SI; Kostić DM; Cinara II; Cvetković SD; Stojanov PL; Velimirović DB; Marković MM; Pejkić SA; Vukotić AM
    Srp Arh Celok Lek; 1997; 125(1-2):24-35. PubMed ID: 17974352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of modified human umbilical vein as an arterial substitute in femoropopliteal reconstructive surgical procedures.
    Lee BY; Trainor FS; Kavner D; McCann WJ
    Surg Gynecol Obstet; 1978 Nov; 147(5):721-5. PubMed ID: 102043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Popliteal artery aneurysms. Factors associated with thromboembolism and graft failure.
    Martelli E; Ippoliti A; Ventoruzzo G; De Vivo G; Ascoli Marchetti A; Pistolese GR
    Int Angiol; 2004 Mar; 23(1):54-65. PubMed ID: 15156131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of human umbilical vein grafts.
    Harris JP; Farey I; Stephen MS; Sheil AG; May J
    Surgery; 1984 Jul; 96(1):23-8. PubMed ID: 6740493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome and cost analysis after femorocrural and femoropedal grafting for critical limb ischaemia.
    Panayiotopoulos YP; Tyrrell MR; Owen SE; Reidy JF; Taylor PR
    Br J Surg; 1997 Feb; 84(2):207-12. PubMed ID: 9052436
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded polytetrafluoroethylene femoropopliteal grafts: forty-eight-month follow-up.
    Evans LE; Webster MW; Brooks DH; Bahnson HT
    Surgery; 1981 Jan; 89(1):16-22. PubMed ID: 7466607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Femoropopliteal bypass with a compliant, composite polyurethane/Dacron graft: short-term results of a multicentre trial.
    Dereume JP; van Romphey A; Vincent G; Engelmann E
    Cardiovasc Surg; 1993 Oct; 1(5):499-503. PubMed ID: 8076085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Autologous vein vs. human umbilical vein for femoropopliteal bypass].
    Flørenes T; Zasada W; Pillgram-Larsen J; Dedichen H
    Tidsskr Nor Laegeforen; 1993 Sep; 113(21):2681-3. PubMed ID: 8266287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The limitations of polytetrafluoroethylene in the reconstruction of femoropopliteal and tibial arteries.
    Hallett JW; Brewster DC; Darling RC
    Surg Gynecol Obstet; 1981 Jun; 152(6):819-21. PubMed ID: 7244961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Femoropopliteal vascular replacement: vein, ePTFE or ovine collagen?].
    Koch G; Gutschi S; Pascher O; Fruhwirth J; Hauser H
    Zentralbl Chir; 1996; 121(9):761-7. PubMed ID: 9012236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preliminary results with the use of expanded microporous polytetrafluoroethylene in vascular occlusive disease of the lower extremity.
    Schreiber S; Watne AL; Fedde CW; McDowell DE
    Am Surg; 1980 Mar; 46(3):165-70. PubMed ID: 7377660
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polytetrafluoroethylene use for above-knee femoropopliteal bypass in critical limb ischemia.
    El-Kayali AA
    Saudi Med J; 2003 Jun; 24(6):669-71. PubMed ID: 12847601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of graft type on patency of infrainguinal arterial bypass grafts.
    Neale ML; Graham JC; Lane RJ; Cheung DS; Appleberg M
    J Am Coll Surg; 1994 Feb; 178(2):155-63. PubMed ID: 8173726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal outcome after tibial arterial bypass.
    Shah DM; Paty PS; Leather RP; Chang BB; Darling RC; Feustel PJ
    Surg Gynecol Obstet; 1993 Sep; 177(3):283-7. PubMed ID: 8356500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of conduits for leg revascularization.
    Weisel RD; Johnston KW; Baird RJ; Drezner AD; Oates TK; Lipton IH
    Surgery; 1981 Jan; 89(1):8-15. PubMed ID: 7466615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term prognosis of femoropopliteal bypass: an analysis of 349 consecutive revascularizations.
    Lau H; Cheng SW
    ANZ J Surg; 2001 Jun; 71(6):335-40. PubMed ID: 11409017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of autologous graft and human umbilical vein graft in femorocrural bypasses--a preliminary report.
    Rondhuis JJ; van Iersel JG; Taks AC
    Neth J Surg; 1985 Apr; 37(2):50-3. PubMed ID: 4000519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Non-greater saphenous vein grafting for infrageniculate bypass.
    Alexander J; Gutierrez C; Katz S
    Am Surg; 2002 Jul; 68(7):611-4. PubMed ID: 12132743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.